上海医药(02607.HK)：普瑞巴林胶囊获得菲律宾药品注册证书

Core Viewpoint - Shanghai Pharmaceuticals (02607.HK) has received approval from the Philippines Food and Drug Administration for the marketing of Pregabalin capsules produced by its subsidiary, Changzhou Pharmaceutical Factory [1] Group 1: Product Approval - The Pregabalin capsules are primarily used for the treatment of postherpetic neuralgia, diabetic peripheral neuropathy, fibromyalgia, and neuropathic pain due to spinal cord injury, as well as for adjunctive treatment of epilepsy [1]